| |
|
|
INV102 for COPD |
| With 24 million patients in the US, COPD (chronic obstructive pulmonary disease), is the 4th leading cause of death in the US and is primarily a consequence of smoking. There is a scientific rationale to expect activity of INV102 in COPD.
|
|
|
|
